Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
International Angiology : a Journal of the International Union of Angiology|December 11, 2012
Thromboelastographic evaluation of blood coagulation in the presence of branded and generic enoxaparinsJ M Walenga, W P Jeske, V Escalante, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Singlet oxygen inhibits agonist-induced P-selectin expression and formation of platelet aggregatesT W Stief, W P Jeske, J Walenga, et al.
Thrombosis Research|October 29, 2000
Human anti-heparin-platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primatesS Ahmad, W P Jeske, J M Walenga, et al.
Archives of Pathology & Laboratory Medicine|November 18, 2000
Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications--a reviewF Fabris, S Ahmad, G Cella, et al.
Journal of Thrombosis and Haemostasis : JTH|September 10, 2005
Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparinM M Prechel, M K McDonald, W P Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Laboratory diagnosis of heparin-induced thrombocytopeniaJ M Walenga, W P Jeske, A R Fasanella, et al.
Seminars in Hematology|February 4, 1999
Laboratory tests for heparin-induced thrombocytopenia: a multicenter studyJ M Walenga, W P Jeske, J J Wood, et al.
Thrombosis Research|April 4, 1998
Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of plateletsW P Jeske, J M Walenga, E Szatkowski, et al.
Seminars in Thrombosis and Hemostasis|June 5, 1999
Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HITJ M Walenga, W P Jeske, D E Wallis, et al.
Biochemistry. Biokhimiia|February 14, 2002
Statin drugs and dietary isoprenoids downregulate protein prenylation in signal transduction and are antithrombotic and prothrombolytic agentsJ W Fenton, W P Jeske, J L Catalfamo, et al.
Pageof 3